Cargando…
Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015
BACKGROUND: Extracorporeal liver support therapies (ELS) are technical options (for bridge-to-recovery as well as bridge-to-transplant) in patients with acute liver dysfunction (e.g. acute liver failure (ALF), acute-on chronic liver failure (AoCLF) or decompensated chronic liver disease (decomp. CLD...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724268/ https://www.ncbi.nlm.nih.gov/pubmed/31481009 http://dx.doi.org/10.1186/s12876-019-1077-y |
_version_ | 1783448954421116928 |
---|---|
author | Wiesmann, Thomas Hoenl, Dominic Wulf, Hinnerk Irqsusi, Marc |
author_facet | Wiesmann, Thomas Hoenl, Dominic Wulf, Hinnerk Irqsusi, Marc |
author_sort | Wiesmann, Thomas |
collection | PubMed |
description | BACKGROUND: Extracorporeal liver support therapies (ELS) are technical options (for bridge-to-recovery as well as bridge-to-transplant) in patients with acute liver dysfunction (e.g. acute liver failure (ALF), acute-on chronic liver failure (AoCLF) or decompensated chronic liver disease (decomp. CLD)) to reduce effects of failing hepatic detoxification functions. The present study investigates the real-life utilization of ELS (annual incidences), mortality rates as well as data regarding specific populations of liver transplantation in Germany. METHODS: Data on patient cases receiving extracorporeal liver support therapy were identified in a nationwide data set from the Federal statistical Office of Germany from 1 January 2007 through 31 December 2015 and analyzed regarding in-hospital mortality, age- and sex-specific distribution and use of ELS in the context of liver transplantation. Mortality rates in patients with primary acute liver dysfunction and secondary acute liver dysfunction (in the context of cardiothoracic surgery) were evaluated. RESULTS: Annual incidences of ELS use remained stable between 0.39/100.000 in 2007 and 0.47/100.000 ELS in 2015. In-hospital mortality rate was 51.49% in the 2886 evaluated patient cases. Mortality was higher in men (56.04%) than in women (43.70) in the observed time period between 2007 and 2015. ELS utilization and case-related liver transplantation rates were low (12.47%). Since 2012, the annual numbers for ELS therapy in cardiosurgical patients exceeded the frequency of ELS utilization in cases of primary liver dysfunction (mortality rates: 68.39% versus 40.63%). CONCLUSIONS: ELS utilization remained stable between 2007 and 2015. Mortality rates are high in this patient population of acute liver dysfunction, especially in combination with case-related cardiothoracic surgery. ELS is rarely used in the setting of liver transplantation. In 2015, more than 50% of all ELS cases in Germany were performed in the context of cardiothoracic surgery. |
format | Online Article Text |
id | pubmed-6724268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67242682019-09-10 Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 Wiesmann, Thomas Hoenl, Dominic Wulf, Hinnerk Irqsusi, Marc BMC Gastroenterol Research Article BACKGROUND: Extracorporeal liver support therapies (ELS) are technical options (for bridge-to-recovery as well as bridge-to-transplant) in patients with acute liver dysfunction (e.g. acute liver failure (ALF), acute-on chronic liver failure (AoCLF) or decompensated chronic liver disease (decomp. CLD)) to reduce effects of failing hepatic detoxification functions. The present study investigates the real-life utilization of ELS (annual incidences), mortality rates as well as data regarding specific populations of liver transplantation in Germany. METHODS: Data on patient cases receiving extracorporeal liver support therapy were identified in a nationwide data set from the Federal statistical Office of Germany from 1 January 2007 through 31 December 2015 and analyzed regarding in-hospital mortality, age- and sex-specific distribution and use of ELS in the context of liver transplantation. Mortality rates in patients with primary acute liver dysfunction and secondary acute liver dysfunction (in the context of cardiothoracic surgery) were evaluated. RESULTS: Annual incidences of ELS use remained stable between 0.39/100.000 in 2007 and 0.47/100.000 ELS in 2015. In-hospital mortality rate was 51.49% in the 2886 evaluated patient cases. Mortality was higher in men (56.04%) than in women (43.70) in the observed time period between 2007 and 2015. ELS utilization and case-related liver transplantation rates were low (12.47%). Since 2012, the annual numbers for ELS therapy in cardiosurgical patients exceeded the frequency of ELS utilization in cases of primary liver dysfunction (mortality rates: 68.39% versus 40.63%). CONCLUSIONS: ELS utilization remained stable between 2007 and 2015. Mortality rates are high in this patient population of acute liver dysfunction, especially in combination with case-related cardiothoracic surgery. ELS is rarely used in the setting of liver transplantation. In 2015, more than 50% of all ELS cases in Germany were performed in the context of cardiothoracic surgery. BioMed Central 2019-09-03 /pmc/articles/PMC6724268/ /pubmed/31481009 http://dx.doi.org/10.1186/s12876-019-1077-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Wiesmann, Thomas Hoenl, Dominic Wulf, Hinnerk Irqsusi, Marc Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 |
title | Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 |
title_full | Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 |
title_fullStr | Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 |
title_full_unstemmed | Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 |
title_short | Extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 |
title_sort | extracorporeal liver support: trending epidemiology and mortality - a nationwide database analysis 2007–2015 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724268/ https://www.ncbi.nlm.nih.gov/pubmed/31481009 http://dx.doi.org/10.1186/s12876-019-1077-y |
work_keys_str_mv | AT wiesmannthomas extracorporealliversupporttrendingepidemiologyandmortalityanationwidedatabaseanalysis20072015 AT hoenldominic extracorporealliversupporttrendingepidemiologyandmortalityanationwidedatabaseanalysis20072015 AT wulfhinnerk extracorporealliversupporttrendingepidemiologyandmortalityanationwidedatabaseanalysis20072015 AT irqsusimarc extracorporealliversupporttrendingepidemiologyandmortalityanationwidedatabaseanalysis20072015 |